Licorice root Glycyrrhiza glabra; Glycyrrhiza uralensis; Glycyrrhiza inflata
Also called: licorice, liquorice, sweet root, gan cao, gan zao, Chinese licorice
Licorice root comes from Glycyrrhiza species, mainly Glycyrrhiza glabra, G. uralensis and G. inflata. It is used as a food ingredient and in supplements and topical products; some oral products have the glycyrrhizin removed.
- Category
- Botanical
- Part used
- Root
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2019 meta-analysis (J Clin Anesth) pooled 5 RCTs (609 adults) of topical licorice applied before intubation versus non-analgesic control, for postoperative sore throat. Route: topical, not oral supplements; no count of oral licorice trials was found. [4]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CMouth and teeth1 topic
CLungs and airways1 topic
CStomach and gut1 topic
CSkin and hair1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Mouth and throat uses (canker sores, sore throat after intubation, bad breath) | C | Some human studies exist, but NCCIH finds not enough high-quality evidence to clearly support licorice for any health condition. [1] |
| Topical gels for eczema and burns | C | NCCIH reports studies of topical licorice gels with unclear evidence. [1] |
| Digestive symptoms | C | NCCIH describes the evidence for digestive symptoms as unclear. [1] |
| COVID-19 | C | NCCIH states there is no good evidence for licorice in COVID-19. [1] |
Main constituents: Glycyrrhizin (glycyrrhizic or glycyrrhizinic acid) [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
Upper limits
- EU Scientific Committee on Food (2003): an upper limit for regular ingestion of 100 mg/day of glycyrrhizinic acid provides sufficient protection for the majority of the population (NOAEL 2 mg/kg bw/day, about 130 mg/person/day). [2]
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter last updated March 20, 2023.
Details and sources - Pregnancy and breastfeedingHealth Canada monograph contraindication: do not use if pregnant; ask a practitioner before use if breastfeeding.
3 statements in the profile.
Details and sources - Interactions with medicines2 listed
Corticosteroids
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked. The profile notes other test results.
Details and sources - FDA new dietary ingredient notifications11 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsStated
Health Canada (monograph dated November 29, 2024), adults 18 and older: 0.6-15 g dried root (or root and rhizome/stolon) per day, or standardized …
Details and sources
- Glycyrrhizin can cause serious effects, including irregular heartbeat and cardiac arrest, especially with large or long-term intake; small amounts have caused severe effects in people who eat a lot of salt or have hypertension, heart or kidney conditions. [1]
- Glycyrrhizinic acid causes cortisol-dependent sodium and water retention (pseudohyperaldosteronism), seen as edema, low blood potassium (hypokalemia) and increased blood pressure. [2]
- The 100 mg/day limit may not protect people with decreased 11-beta-hydroxysteroid dehydrogenase-2 activity, prolonged gastrointestinal transit time, or hypertension or electrolyte- or water-balance disorders. [2]
- Pregnancy: about 250 g of licorice per week is unsafe and can increase the risk of delivery before 38 weeks. Little is known about safety while breastfeeding. [1]
- Oral licorice without glycyrrhizin may be safe for up to 4 months; topical licorice may be safe short-term. [1]
Interactions
| With | What happens |
|---|---|
| Corticosteroids | Interactions between licorice and corticosteroids have been reported. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Regulatory status
- US: generally considered safe as a food ingredient; also sold as a dietary supplement, which the FDA does not approve before sale. [1]
- EU: the EMA lists an EU herbal monograph for licorice root (Liquiritiae radix) in the cough-and-cold and gastrointestinal areas; final revision 1 first published 20/07/2026. [3]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Glycyrrhizin (glycyrrhizinic acid), a major component at 4% to 12% of licorice root Molecular formula C42H62O16 (LiverTox) [P1]
- Glycyrrhizinic acid Glycoside; its aglycone, glycyrrhetic acid, is the biologically active form [P2]
- Flavonoids, flavones, saponins and chalcones (to which medicinal components are usually attributed) Flavonoids; saponins; chalcones [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 11 entries naming licorice, liquorice or Glycyrrhiza (earliest NDI 245 submitted 2003-07-22; most recent NDI 960 submitted 2016-11-13). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P3]
- 21 CFR 184.1408 (licorice and licorice derivatives from Glycyrrhiza glabra or other Glycyrrhiza species) sets maximum glycyrrhizin levels in foods as served, including 0.5% in vitamin or mineral dietary supplements and 0.1% in all other foods not listed; not permitted as a nonnutritive sweetener in sugar substitutes. [P4]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of licorice or glycyrrhizin was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P5]
- NTP technical reports list checked 2026-10-29: no report on licorice or glycyrrhizin. [P6]
- EU Scientific Committee on Food (2003): glycyrrhizinic acid and glycyrrhetic acid are considered non-genotoxic; a limited chronic study in mice detected no carcinogenic potential; no rat carcinogenicity study is available. [P2]
Liver (NIH LiverTox)
- LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter last updated March 20, 2023. [P1]
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P9]
- Glycyrrhizin content — The EU Scientific Committee on Food (2003) considered an upper limit of 100 mg/day glycyrrhizinic acid for regular ingestion; repeated intake causes (through glycyrrhetic acid) increased sodium and water retention and potassium excretion, which can result in edema, hypokalemia and increased blood pressure. [P2]
- Glycyrrhizin content (US food uses) — 21 CFR 184.1408 sets maximum glycyrrhizin levels by food category, including 0.5% in vitamin or mineral dietary supplements. [P4]
- Glycyrrhizin assay for deglycyrrhizinated extracts — Some licorice extracts are deglycyrrhizinated to reduce mineralocorticoid toxicities (LiverTox). [P1]
Supply and conservation
- Glycyrrhiza glabra, IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P10]
Absorption in people
- SCF (2003): glycyrrhizinic acid itself is hardly absorbed; it is hydrolysed in the gut, most likely by bacteria, to glycyrrhetic acid, which is readily and virtually completely absorbed, reaching maximum plasma levels about 8-12 h after oral intake in humans; enterohepatic circulation may prolong active plasma levels, especially with slow gastrointestinal transit. [P2]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- Health Canada (monograph dated November 29, 2024), adults 18 and older: 0.6-15 g dried root (or root and rhizome/stolon) per day, or standardized extracts providing 60-600 mg glycyrrhizin per day; ask a practitioner for use beyond 4 weeks. [P8]
Pregnancy and breastfeeding
- Health Canada monograph contraindication: do not use if pregnant; ask a practitioner before use if breastfeeding. [P8]
- NCCIH: about 250 g of licorice per week is unsafe in pregnancy and can increase the risk of delivery before 38 weeks; little is known about safety while breastfeeding. [P7]
- LiverTox: licorice should not be used during pregnancy. [P1]
Sources for this profile
- NIH LiverTox. Licorice (last update March 20, 2023), 2023-03-20. ncbi.nlm.nih.gov
- European Commission, Scientific Committee on Food. Opinion on glycyrrhizinic acid and its ammonium salt (SCF/CS/ADD/EDUL/225 Final, 10 April 2003), 2003-04-10. ec.europa.eu
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 184.1408 Licorice and licorice derivatives (up to date as of 10/22/2026), 2026-10-22. ecfr.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- NCCIH. Licorice Root (Last Updated: April 2025), 2025-04. nccih.nih.gov
- Health Canada, NNHPD. Monograph: Licorice (date 2024-11-29), 2024-11-29. webprod.hc-sc.gc.ca
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Glycyrrhiza glabra L., 2026-10-29. api.gbif.org
Sources
- NCCIH. Licorice Root (Last Updated: April 2025), 2025-04. nccih.nih.gov
- European Commission, Scientific Committee on Food. Opinion on glycyrrhizinic acid and its ammonium salt (SCF/CS/ADD/EDUL/225 Final, 10 April 2003), 2003-04-10. ec.europa.eu
- European Medicines Agency. Liquiritiae radix (herbal medicine page), 2026-07-20. ema.europa.eu
- Kuriyama A, Maeda H. Topical application of licorice for prevention of postoperative sore throat in adults: a systematic review and meta-analysis. J Clin Anesth 2019;54:25-32 (PMID 30391446), 2018-11-02. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.